In this study, we provide the first line of evidence for the selective upregulation of SLC7A2/CAT2 compared to other arginine transporter family proteins (SLC7A1, A3 and A4) in HD cellular models and patients. This evidence concerns the gene SLC7A2 and Huntington disease.